 | • レポートコード：D0-MOR-AP0072 • 出版社/出版日：Mordor Intelligence / 2020年4月20日 • レポート形態：英文、PDF、121ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：健康管理 |
| Single User | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,110,000 (USD7,500) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、吻合装置の世界市場について調査・分析した資料で、吻合装置の市場概要、動向、セグメント別市場規模、地域別分析、競争状況、企業情報、市場機会分析などで構成されています。 |
The Anastomosis Devices Market studied was anticipated to grow with a CAGR of 7.0% during the forecast period. The major factors driving the growth of the market are a rise in the number of cardiac, gastrointestinal surgeries across the globe which resulted in their usage during the procedures. Higher demand for surgeries like CABG (Coronary Artery Bypass Grafting), Partial colectomy and other thoracic surgeries due to the global prevalence of various coronary heart diseases and the rise in the geriatric population. For instance, according to WHO 17.9 million of the population are suffering from death every year. Additionally, cardiac diseases like coronary heart disease, hypertension, and stroke were ranked as the highest cause of deaths worldwide. Furthermore, increased adoption of endoscopic surgeries, favorable reimbursement policies, and technological advancements are likely to fuel the growth of the market.
Key Market Trends
The Cardiovascular Surgery Segment is Expected to Hold the Largest Market Share in the Anastomosis Devices Market
Cardiovascular surgeries by the application are expected to witness the largest market share in the anastomosis devices market during the forecast period. This dominance is due to the increased use of various devices such as the surgical staplers, and surgical sealants & adhesives in various cardiac surgeries. Higher demand for these devices in aortic surgery, arrhythmia surgery, myectomy, and CABG procedures can be due to their ability to minimize the risk of complications and reduce anastomotic leaks. Furthermore, a rising number of cardiac diseases demands technologically advanced products propelling the growth of the segment. On the other hand, the gastrointestinal surgeries segment is anticipated to witness the highest CAGR over the course of the forecast period. The lucrative growth of the segment can be due to the rising number of gastrointestinal cancers across the world. As per the American Cancer Society’s estimates for the year 2020, stomach cancer affects about 27,600 and causing 11,010 deaths in the United States. Also, the report states that surgery like endoscopic resection, partial gastrectomy, etc., can only offer a realistic chance for cure of this type of cancer. Thus, the adoption of surgery as an essential part of the treatment for many different stages of stomach cancer is expected to boost the growth of the segment.
North America Dominates the Market and Expected to do Same in the Forecast Period.
North America is expected to dominate the overall anastomosis devices market throughout the forecast period. The major factors attributing to the growth are the rise in the global prevalence of multiple cardiovascular indications like CAD, strokes and gastric cancers like adenocarcinoma, lymphoma, etc., Thus, a rise in surgical procedures increased the demand for these surgical devices. As per the American Heart Association, in 2018, nearly 92.1 million individuals in the U.S. suffered from cardiovascular diseases leading to 3244 heart transplantations. Thus, higher demand for these devices during surgical procedures drives the market in the region. Also, growing deskbound lifestyle, increasing geriatric population with chronic diseases in the region contribute to its outstanding share of revenue propelling the global anastomosis devices market.
Competitive Landscape
The anastomosis market is moderately competitive and consists of several major players. Few of the key players are developing novel products and technologies to compete with the products trending in the market. For instance, in September 2019, Ethicon launched its ECHELON CIRCULAR Powered Circular Stapler which utilizes an innovative Gripping Surface and 3D Stapling Technologies. The stapler is designed to reduce leaks without compromising perfusion. Such innovative launches are expected to impel the global anastomosis market growth throughout the forecast period. Some of the companies which are currently dominating the market are Medtronic Plc, LivaNova PLC, Getinge AB, Johnson & Johnson (Ethicon US, LLC.), and Baxter International Inc. (Synovis Micro Companies Alliance, Inc.)
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rise in Number of Surgical Procedures like Colectomy, CABG and Others
4.2.2 Availability of Technologically Advanced Products and Reimbursement Policies
4.3 Market Restraints
4.3.1 Adoption of Minimally Invasive Procedures like Percutaneous Coronary Interventions
4.3.2 Highly Expensive Treatments and Lack of Advanced Healthcare Infrastructure
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Usage
5.1.1 Disposable
5.1.2 Reusable
5.2 By Type
5.2.1 Surgical Staplers
5.2.2 Surgical Sutures
5.2.3 Surgical Sealants and Adhesives
5.2.4 Others
5.3 By Application
5.3.1 Cardiovascular Surgery
5.3.2 Gastrointestinal Surgery
5.3.3 Others
5.4 Geography
5.4.1 North America
5.4.1.1 United states
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 BAXTER INTERNATIONAL INC. (SYNOVIS MICRO COMPANIES ALLIANCE, INC.)
6.1.2 Medtronic Plc
6.1.3 LivaNova PLC
6.1.4 Getinge AB
6.1.5 Johnson & Johnson (Ethicon US, LLC.)
6.1.6 Meril Life Sciences Pvt. Ltd.
6.1.7 Becton, Dickinson and Company
6.1.8 Intuitive Surgical, Inc.
6.1.9 Boston Scientific Corporation
6.1.10 B. Braun Melsungen AG
7 MARKET OPPORTUNITIES AND FUTURE TRENDS